Zepp Health Price to Book Ratio 2017-2023 | ZEPP

Historical price to book ratio values for Zepp Health (ZEPP) over the last 10 years. The current price to book ratio for Zepp Health as of May 10, 2024 is 0.15.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Zepp Health Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-05-10 0.86 inf
2023-09-30 1.15 0.00
2023-06-30 1.14 0.00
2023-03-31 1.31 0.00
2022-12-31 1.45 $6.35 0.23
2022-09-30 1.37 0.00
2022-06-30 1.85 0.00
2022-03-31 2.88 0.00
2021-09-30 7.77 0.00
2021-03-31 10.42 0.00
2020-12-31 11.47 $6.69 1.71
2020-09-30 12.43 0.00
2020-06-30 11.96 0.00
2020-03-31 12.69 0.00
2019-12-31 11.63 $5.80 2.01
2019-09-30 9.68 0.00
2019-06-30 9.68 0.00
2019-03-31 12.67 0.00
2018-12-31 9.51 $4.36 2.18
2018-09-30 10.35 0.00
2018-06-30 9.53 0.00
2018-03-31 10.28 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.053B $0.351B
Zepp Health Corp. developed a platform of proprietary technology including AI chips, biometric sensors and health data algorithms, which drive a broadening line of smart health products for consumers and analytics services for insurers, healthcare providers, employers, drug and treatment companies. Zepp Health Corp., formerly known as Huami Corporation, is based in CUPERTINO, Calif.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $38.069B 20.90
Inspire Medical Systems (INSP) United States $4.986B 0.00
Axonics (AXNX) United States $3.440B 0.00
10x Genomics (TXG) United States $3.097B 0.00
IRhythm Technologies (IRTC) United States $3.080B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.900B 0.00
Azenta (AZTA) United States $2.877B 156.36
Enovis (ENOV) United States $2.801B 20.76
Hims & Hers Health (HIMS) United States $2.633B 0.00
Privia Health (PRVA) United States $2.132B 119.80
Schrodinger (SDGR) United States $1.644B 0.00
Omnicell (OMCL) United States $1.383B 47.81
Phreesia (PHR) United States $1.205B 0.00
Standard BioTools (LAB) United States $0.696B 0.00
Fulgent Genetics (FLGT) United States $0.651B 0.00
Definitive Healthcare (DH) United States $0.627B 0.00
Talkspace (TALK) United States $0.477B 0.00
Clover Health Investments (CLOV) United States $0.406B 0.00
Health Catalyst (HCAT) United States $0.378B 0.00
Pulmonx (LUNG) United States $0.326B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.306B 0.00
Butterfly Network (BFLY) United States $0.215B 0.00
P3 Health Partners (PIII) United States $0.212B 0.00
Outset Medical (OM) United States $0.159B 0.00
American Well (AMWL) United States $0.139B 0.00
TruBridge (TBRG) United States $0.129B 7.07
MSP Recovery (LIFW) United States $0.121B 0.00
Augmedix (AUGX) United States $0.109B 0.00
111 (YI) China $0.095B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.078B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.061B 0.00
EUDA Health Holdings (EUDA) Singapore $0.055B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Movano (MOVE) United States $0.043B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.021B 0.00
CareCloud (CCLD) United States $0.020B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00